Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of very low dose decitabine combinate
with gemcitabine in the first-line treatment of locally advanced, unresectable and metastatic
pancreatic cancer.
Phase:
N/A
Details
Lead Sponsor:
First Hospital of Jilin University The First Hospital of Jilin University